|
| 37556401 | Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study. | Inflamm Bowel Dis | 2024 |
| 37556401 | Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study. | Inflamm Bowel Dis | 2024 |
| 34971808 | Novel Diagnostic Autoantibodies Against Endothelial Protein C Receptor in Patients With Ulcerative Colitis. | Clin Gastroenterol Hepatol | 2023 |
| 35998072 | Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD. | Inflamm Bowel Dis | 2023 |
| 37762524 | A Paratope-Enhanced Method to Determine Breadth and Depth TCR Clonal Metrics of the Private Human T-Cell Vaccine Response after SARS-CoV-2 Vaccination. | Int J Mol Sci | 2023 |
| 37836428 | Microbiota-Dependent Upregulation of Bitter Taste Receptor Subtypes in the Mouse Large Intestine in High-Fat Diet-Induced Obesity. | Nutrients | 2023 |
| 38005976 | Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection. | Vaccines (Basel) | 2023 |
| 37773982 | Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2023 |
| 36508344 | Environmental Interaction of Resolved Human Cytomegalovirus Infection With Crohn's Disease Location. | Inflamm Bowel Dis | 2023 |
| 36625223 | Long-term durability of antibody responses after SARS-CoV-2 vaccination and influencing factors. | J Intern Med | 2023 |
| 34971808 | Novel Diagnostic Autoantibodies Against Endothelial Protein C Receptor in Patients With Ulcerative Colitis. | Clin Gastroenterol Hepatol | 2023 |
| 38005976 | Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection. | Vaccines (Basel) | 2023 |
| 37836428 | Microbiota-Dependent Upregulation of Bitter Taste Receptor Subtypes in the Mouse Large Intestine in High-Fat Diet-Induced Obesity. | Nutrients | 2023 |
| 37773982 | Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2023 |
| 37762524 | A Paratope-Enhanced Method to Determine Breadth and Depth TCR Clonal Metrics of the Private Human T-Cell Vaccine Response after SARS-CoV-2 Vaccination. | Int J Mol Sci | 2023 |
| 36625223 | Long-term durability of antibody responses after SARS-CoV-2 vaccination and influencing factors. | J Intern Med | 2023 |
| 36508344 | Environmental Interaction of Resolved Human Cytomegalovirus Infection With Crohn's Disease Location. | Inflamm Bowel Dis | 2023 |
| 35998072 | Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD. | Inflamm Bowel Dis | 2023 |
| 35229726 | Fungal microbiome in inflammatory bowel disease: a critical assessment. | J Clin Invest | 2022 |
| 35397000 | The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy. | Inflamm Bowel Dis | 2022 |
| 35464463 | Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease. | Front Immunol | 2022 |
| 35971134 | Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome. | Genome Med | 2022 |
| 35765315 | Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies. | Open Forum Infect Dis | 2022 |
| 35613792 | Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis. | BMJ Open | 2022 |
| 36188190 | Evidence of premature lymphocyte aging in people with low anti-spike antibody levels after BNT162b2 vaccination. | iScience | 2022 |
| 36589457 | Magnetic resonance imaging for characterization of hepatocellular carcinoma metabolism. | Front Physiol | 2022 |
| 35229726 | Fungal microbiome in inflammatory bowel disease: a critical assessment. | J Clin Invest | 2022 |
| 35613792 | Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis. | BMJ Open | 2022 |
| 35765315 | Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies. | Open Forum Infect Dis | 2022 |
| 35397000 | The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy. | Inflamm Bowel Dis | 2022 |
| 35464463 | Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease. | Front Immunol | 2022 |
| 36589457 | Magnetic resonance imaging for characterization of hepatocellular carcinoma metabolism. | Front Physiol | 2022 |
| 35971134 | Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome. | Genome Med | 2022 |
| 36188190 | Evidence of premature lymphocyte aging in people with low anti-spike antibody levels after BNT162b2 vaccination. | iScience | 2022 |
| 33440171 | Role of dietary fiber in the recovery of the human gut microbiome and its metabolome. | Cell Host Microbe | 2021 |
| 36777269 | Performance Characteristics of a Clinical Decision Support Tool for Disease Complications in Crohn's Disease. | Crohns Colitis 360 | 2021 |
| 33707263 | <i>Debaryomyces</i> is enriched in Crohn's disease intestinal tissue and impairs healing in mice. | Science | 2021 |
| 33795870 | Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2. | Nat Med | 2021 |
| 33579769 | Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study. | BMJ Open | 2021 |
| 34047304 | Adverse Events After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease. | Am J Gastroenterol | 2021 |
| 33655279 | Prior COVID-19 Infection and Antibody Response to Single Versus Double Dose mRNA SARS-CoV-2 Vaccination. | medRxiv | 2021 |
| 33440171 | Role of dietary fiber in the recovery of the human gut microbiome and its metabolome. | Cell Host Microbe | 2021 |
| 33821287 | Adverse Events Following SARS-CoV-2 mRNA Vaccination Among Patients with Inflammatory Bowel Disease. | medRxiv | 2021 |
| 33211672 | BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers. | J Clin Invest | 2021 |
| 33098885 | Prevalence and Effect of Genetic Risk of Thromboembolic Disease in Inflammatory Bowel Disease. | Gastroenterology | 2021 |
| 33141762 | Mitochondrial dysfunction in inflammatory bowel disease alters intestinal epithelial metabolism of hepatic acylcarnitines. | J Clin Invest | 2021 |
| 33160965 | Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease. | Gastroenterology | 2021 |
| 34687733 | Symptomology following mRNA vaccination against SARS-CoV-2. | Prev Med | 2021 |
| 34633830 | Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease. | Ann Intern Med | 2021 |
| 34909797 | Post-Vaccination Symptoms after A Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease. | medRxiv | 2021 |